vimarsana.com

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript April 29, 2024 Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the Q1 2024 […]

Related Keywords

China ,Chinese ,Max Krakowiak ,Our Life Sciences Instrument ,Tour Life Sciences ,Specialty Pharma Services ,Life Sciences ,Reagents Technology Licensing ,Our Signal Software ,Revvity Omics Lab ,Investor Relations ,Life Sciences Instrument ,Signal Software ,Newborn Screening ,Applied Genomics ,Revvity ,Steve Willoughby ,Prahlad Singh ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.